- Investing Ideas
- /
- Swedish Strong Balance Sheet Stocks
Swedish Strong Balance Sheet Stocks
Results
596
0 new
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
596 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
HIFA B | SEK 3.60 | 16.9% | 46.3% | SEK 219.0m | n/a | PE11.1x | n/a | 0% | Commercial Services | ||
BOL | SEK 350.80 | 0.5% | 6.0% | SEK 95.9b | SEK 357.81 | PE20.5x | E21.8% | 2.1% | Materials | ||
SES | SEK 2.35 | -1.3% | 49.7% | SEK 1.9b | SEK 6.50 | PS28.1x | E-21.6% | n/a | Commercial Services | ||
RROS | SEK 11.70 | 1.6% | -6.5% | SEK 1.8b | SEK 13.50 | PE1785.1x | E55.1% | 4.3% | Materials | ||
ARISE | SEK 51.40 | 2.4% | 23.6% | SEK 2.1b | SEK 77.50 | PE10.5x | E30.5% | 2.3% | Utilities | ||
EPI A | SEK 213.90 | 2.9% | 2.9% | SEK 251.4b | SEK 205.40 | PE28.2x | E9.0% | 1.8% | Capital Goods | ||
BOUL | SEK 9.94 | -3.0% | -13.1% | SEK 386.0m | SEK 10.90 | PE14.4x | E21.5% | 0% | Healthcare | ||
DVYSR | SEK 110.00 | -0.9% | 46.7% | SEK 1.8b | SEK 123.27 | PS10x | E107.9% | n/a | Pharmaceuticals & Biotech | ||
OX2 | SEK 59.45 | 0.5% | -21.6% | SEK 16.2b | SEK 66.50 | PE18.4x | E30.3% | n/a | Capital Goods | ||
MAGLE | SEK 43.00 | 1.4% | 22.2% | SEK 464.4m | SEK 40.00 | PE38x | E35.4% | n/a | Pharmaceuticals & Biotech | ||
BRG B | SEK 44.50 | -0.2% | 46.9% | SEK 1.5b | SEK 42.33 | PB0.9x | E104.7% | 4.5% | Materials | ||
SMG | SEK 0.79 | 0% | 16.9% | SEK 14.6m | n/a | PE6.4x | n/a | n/a | Media | ||
ASPIRE | SEK 85.10 | -2.2% | 41.6% | SEK 4.0b | SEK 106.54 | PE20.4x | E16.6% | 0% | Consumer Services | ||
MEDHLP | SEK 3.00 | 0.7% | -20.6% | SEK 91.3m | n/a | PS1x | E89.2% | n/a | Healthcare | ||
MSON B | SEK 10.48 | -2.8% | 29.5% | SEK 1.5b | n/a | PB0.5x | E74.0% | 0% | Food, Beverage & Tobacco | ||
CDMIL | SEK 16.90 | 12.7% | 228.2% | SEK 230.2m | n/a | PE77x | S8.3% | n/a | Software | ||
MEKO | SEK 117.80 | -1.8% | 11.1% | SEK 6.6b | SEK 135.00 | PE16.9x | E23.5% | 3.1% | Retail | ||
SGG | SEK 72.90 | -1.2% | -2.1% | SEK 840.6m | SEK 90.00 | PE41.1x | E49.4% | n/a | Tech | ||
DIVIO B | SEK 0.11 | -0.9% | -46.6% | SEK 20.5m | n/a | PB19x | n/a | n/a | Software | ||
HOLM B | SEK 429.40 | 3.2% | 7.2% | SEK 68.3b | SEK 431.50 | PE22.3x | E7.2% | 2.7% | Materials | ||
NORVA | SEK 28.90 | -1.9% | 9.9% | SEK 5.3b | SEK 34.25 | PE25x | E13.8% | n/a | Commercial Services | ||
BHG | SEK 18.21 | 8.9% | 24.8% | SEK 3.3b | SEK 18.50 | PB0.5x | E136.4% | n/a | Retail | ||
EKTA B | SEK 67.00 | -1.0% | -19.9% | SEK 25.6b | SEK 76.38 | PE19.7x | E14.4% | 3.6% | Healthcare | ||
COEGIN | SEK 7.28 | -2.2% | -24.7% | SEK 101.2m | SEK 8.50 | PB4.4x | S95.0% | n/a | Pharmaceuticals & Biotech |